Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2023-04-28 00:00:00 ET · period of report 2023-04-27 · accession 0001127602-23-013710 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-28 | 2023-04-27 | MAIA | Louie Ngar Yee | Dir | P - Purchase | $2.25 | +48.0K | 976.6K | +5% | +$108.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-27 | P | A | 48,000 | $2.25 | 976,584 | D | — | — |